HPRA regulatory notice: Peptides Lab Ireland supplies all compounds strictly for in-vitro laboratory and scientific research. They are not licensed medicines and are not for human or veterinary use.
Pinealon is a very short peptide that has started to appear in Irish searches alongside better-known names such as Epitalon. It is only three amino acids long, which makes it one of the smallest compounds sold as a research peptide. This guide explains what Pinealon is, where it came from, what laboratory studies have looked at, and where the evidence is still thin. It is written for researchers and curious readers, and it is not health advice of any kind.
For laboratory research use only. Pinealon is not a licensed medicine in Ireland or anywhere in the EU, and nothing here suggests it should be used by people or animals.
What is Pinealon?
Pinealon is a synthetic tripeptide with the sequence glutamic acid, aspartic acid and arginine. In the shorthand that chemists use, that is written Glu-Asp-Arg, or simply EDR. Because it has just three building blocks, it has a small molecular weight and a simple structure compared with most peptides on the market.
If you are new to peptides in general, our guide What are peptides? covers the basics: what a peptide is, how it differs from a protein, and why scientists study them.
Pinealon belongs to a family that its developers call “peptide bioregulators”. These are very short peptides, usually two to four amino acids long, that were first described by researchers in St Petersburg, Russia, from the 1980s onwards. The group’s idea was that short peptides taken from particular tissues might carry tissue-specific signals.
Where does the name Pinealon come from?
The name links the peptide to the pineal gland, a small gland deep in the brain that makes melatonin and helps set daily rhythms. The same research group also developed Epitalon, a four-amino-acid peptide that was also linked to pineal research. You can read more about that compound in our article Epitalon explained.
Despite the name, Pinealon is not a pineal hormone. It is a laboratory-made sequence that the developers studied mostly in brain and nerve cell models. The name is best seen as a label, not a description of how it works.
How is Pinealon different from larger peptides?
Most peptides studied in labs, such as BPC-157 or GHK-Cu, act by binding to a receptor on the outside of a cell or by carrying a metal ion. Pinealon is so small that its developers proposed a different idea: that it might pass into cells and even into the cell nucleus, where it could interact directly with DNA and the proteins that pack it.
That idea is unusual. Most short peptides are broken down quickly by enzymes called peptidases, and very few are thought to reach the nucleus intact. So the claim that a tripeptide could change how genes are read is a bold one, and it needs strong independent evidence before it can be accepted.
What does the research say about how Pinealon works?
The most cited work on the EDR peptide comes from the same research network that developed it. A 2020 review in the journal Molecules set out their proposed mechanism. The authors suggested that EDR might influence the activity of certain genes and the making of proteins linked to the health of nerve cells, including proteins involved in the small branches, called dendritic spines, that let nerve cells connect with each other (Khavinson and colleagues, 2020).
The review discussed results from cell cultures and mouse models used to study Alzheimer’s disease. In those models, the authors reported that the peptide was linked to changes in the number of dendritic spines and in the activity of genes tied to nerve cell function. It is important to be clear that these are laboratory and animal findings, and that the review was written by the group that developed the peptide.
Can a three-amino-acid peptide really bind to DNA?
This is one of the more interesting questions in the Pinealon literature. A 2019 study in the Journal of Physical Chemistry B used computer simulations, known as molecular dynamics, to model how the Glu-Asp-Arg peptide might sit next to a strand of DNA. The authors looked at how charged particles in solution, such as sodium, potassium and magnesium ions, change that interaction.
They reported that metal ions can act as bridges between the negatively charged parts of the peptide and the negatively charged backbone of DNA. In other words, the salt environment matters a great deal to whether the two molecules stick together at all (2019, J Phys Chem B).
Simulation studies are useful because they can test whether an idea is physically possible. But a model on a computer is not the same as proof that something happens inside a living cell. It shows a plausible route, not a confirmed one.
What has Pinealon been studied for in the lab?
Published work on the EDR peptide has looked at a handful of themes:
- Nerve cell models. Most papers focus on brain cells grown in a dish, often under oxidative stress, which means exposing cells to chemicals that create damaging reactive oxygen molecules.
- Ageing models. Several studies compare tissue or cells from young and old animals, looking at markers of cell growth and cell death.
- Skin cell culture. A 2012 study in the Bulletin of Experimental Biology and Medicine looked at how a group of short “bioregulatory” tripeptides, including EDR, affected skin cells taken from young and old rats. The authors measured markers of cell renewal and ageing in the cultures (2012, Bull Exp Biol Med).
- Gene and protein expression. Some work has looked at whether the peptide changes the levels of particular proteins in cultured cells.
Across all of these, the common thread is that the work is early-stage. Most of it is in cells or rodents, and most of it comes from one research school.
How strong is the evidence for Pinealon?
Honestly, the evidence is limited. Here are the main issues a careful researcher should keep in mind:
- One main research group. Most papers come from the developers and their partners. Independent replication by unrelated labs is rare.
- Small studies. Many studies use small numbers of animals or cell cultures, which makes chance findings more likely.
- Some papers are only in Russian. A share of the literature is published in Russian-language journals, which can make it harder for other scientists to check methods in detail.
- Mechanism is still a proposal. The idea that a tripeptide enters the nucleus and acts on DNA is interesting, but it is not settled science.
None of this means the research is wrong. It means the questions are still open, and that strong claims you may see online go well beyond what the published papers show.
How does Pinealon compare with Epitalon?
Pinealon and Epitalon are often mentioned together because they come from the same research school and both carry a “pineal” link in their story. There are some clear differences:
- Size. Pinealon has three amino acids (Glu-Asp-Arg). Epitalon has four (Ala-Glu-Asp-Gly).
- Research focus. Epitalon work has focused more on telomerase and cell ageing. Pinealon work has focused more on nerve cells and oxidative stress.
- Evidence base. Epitalon has a somewhat larger body of published work, though it faces many of the same questions about independent replication.
If you are planning a study that covers more than one compound, our guide to the best-studied research peptides groups peptides by research area and explains how to judge how well studied each one is.
What should Irish labs check before sourcing Pinealon?
Because Pinealon is so small, it is relatively simple to make, but that also means low-quality material is easy to sell. A few checks help:
- A batch Certificate of Analysis. Ask for a CoA that matches the batch number on the vial, with HPLC purity and mass spectrometry identity results. Our guide to reading a peptide CoA explains what each section means.
- The correct mass. The mass spectrometry result should match the expected mass of the Glu-Asp-Arg sequence. A wrong mass means a wrong product.
- Clear labelling. The vial should state the sequence, the amount, the batch number and that it is for research use only.
- A supplier that does not make health claims. In Ireland, products sold with health or medical claims fall under the rules of the Health Products Regulatory Authority. A research supplier should not promise effects in people.
How should Pinealon be stored in the lab?
Like most freeze-dried peptides, Pinealon is most stable as a dry powder kept cold, dark and dry. General good practice is to store sealed vials in a freezer, keep them away from light and moisture, and let a vial reach room temperature before opening so that water does not condense inside. Our article on peptide storage and shelf life covers this in more detail, including how long freeze-dried peptides usually stay stable.
Is Pinealon legal in Ireland?
Pinealon is not an approved medicine in Ireland or the EU. It can be supplied as a research chemical for laboratory work, as long as it is not marketed or sold for people to take. Anyone selling it with health claims, or as something to take, would be stepping into the area of unlicensed medicines, which the HPRA regulates. This is general information, not legal advice.
What are the open questions in Pinealon research?
The main questions researchers are still asking include:
- Does the peptide survive long enough in biological fluids to reach cells in a meaningful amount?
- Can independent labs repeat the reported effects in nerve cell and ageing models?
- Is the proposed DNA interaction something that happens in living cells, or only in simulations and test tubes?
- How does Pinealon compare with a scrambled version of the same three amino acids, which is the kind of control that helps show whether the exact sequence matters?
Answers to these would do far more to settle the debate than any number of online reviews.
Frequently asked questions
What is Pinealon made of?
Pinealon is a tripeptide made of three amino acids: glutamic acid, aspartic acid and arginine, written as Glu-Asp-Arg or EDR.
Is Pinealon the same as Epitalon?
No. They come from the same research school, but Epitalon has four amino acids and a different sequence. They have been studied for different questions.
Is Pinealon a hormone?
No. Despite the name, it is not a pineal gland hormone such as melatonin. It is a short synthetic peptide.
Has Pinealon been approved by any regulator?
It is not an approved medicine in Ireland, the UK or the EU.
Can I buy Pinealon in Ireland?
It can be bought from research suppliers for laboratory use only. Always ask for a batch CoA and check that the supplier makes no health claims.
Who should I contact with a question about a batch?
You can email our team at [email protected] with your batch number and we will send the matching Certificate of Analysis.
References
- EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules (2020). PubMed PMID 33396470
- Role of Mono- and Divalent Ions in Peptide Glu-Asp-Arg-DNA Interaction. J Phys Chem B (2019). PubMed PMID 30762356
- Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats. Bull Exp Biol Med (2012). PubMed PMID 22803085
For laboratory research use only. Nothing on this page is medical advice, and none of our compounds are for human or animal consumption. Questions about a batch, a Certificate of Analysis or an order can go to [email protected].